Jove
Visualize
Contact Us

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

16.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.8K
Leaky Scanning02:28

Leaky Scanning

5.3K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K
Viral Mutations00:36

Viral Mutations

35.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
35.1K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

3.3K
3.3K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

235
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
235

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Species Diversity of Mosquitoes (Diptera: Culicidae) in Various Coastal Bioecological Regions of Southern Iran.

Journal of tropical medicine·2026
Same author

Emerging Klebsiella pneumoniae co-harboring carbapenemase genes and hypervirulence determinants in Iran: a molecular and phenotypic investigation.

Molecular biology reports·2026
Same author

Evaluation of nanoliposomal quercetin - paromomycin and clindamycin on cutaneous leishmaniasis skin lesions in BALB/c mice.

Parasitology·2026
Same author

Molecular Evaluation of Expression Changes in Genes Associated With Colistin Resistance and Virulence Development in <i>Salmonella enterica</i> From Two Iran Hospitals.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale·2025
Same author

Nanomaterial-Enhanced Electrochemical Sensors for Clinical Monitoring of Acyclovir: Integration Into Molecular Diagnostics.

Journal of clinical laboratory analysis·2025
Same author

Innovative nanosensing methods for lysozyme identification.

Enzyme and microbial technology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 17, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

SARS-CoV-2 Lambda (C.37): An emerging variant of concern?

Mohammad Darvishi1, Farid Rahimi2, Amin Talebi Bezmin Abadi3

  • 1Infectious Diseases and Tropical Medicinal Research Center, AJA University of Medical Sciences, Tehran, Iran.

Gene Reports
|October 11, 2021
PubMed
Summary

New SARS-CoV-2 variants like Lambda exhibit mutations affecting vaccine effectiveness and immune evasion. Widespread vaccination and hygiene protocols are crucial to control the pandemic

Keywords:
C.37COVID-19GISAIDGR/452Q.V1LambdaPandemicSARS-CoV-2Sequencing analysis

More Related Videos

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.9K

Related Experiment Videos

Last Updated: Oct 17, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.9K

Area of Science:

  • Virology and Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Emergence of numerous SARS-CoV-2 variants (Alpha, Beta, Gamma, Delta, Lambda, etc.) with increased infectivity and transmissibility.
  • Viral genome data indicate these variants have significantly shaped COVID-19 case trajectories globally.
  • Specific variants like Lambda (C.37), initially identified in Peru, have spread rapidly across continents.

Purpose of the Study:

  • To analyze the characteristics and implications of emerging SARS-CoV-2 variants.
  • To understand the impact of variant mutations on vaccine effectiveness and antibody neutralization.
  • To assess the potential clinical consequences and healthcare system strain caused by widespread variant dissemination.

Main Methods:

  • Analysis of viral genome data to track variant emergence and spread.
  • Examination of mutations within viral variants, particularly those affecting the spike protein.
  • Review of scientific literature on the implications of these mutations for immunity and disease progression.

Main Results:

  • Several SARS-CoV-2 variants (Alpha, Beta, Gamma, Delta, Eta, Iota, Kappa, Lambda) exhibit high infectivity and transmissibility.
  • Mutations in variants, especially in the spike protein, can affect vaccine efficacy and antibody neutralization.
  • The Lambda variant shows significant spread, with mutations potentially aiding viral invasion and immune evasion.

Conclusions:

  • Widespread dissemination of SARS-CoV-2 variants poses risks of severe clinical outcomes, prolonged hospitalizations, and system strain.
  • Mutations in variants necessitate ongoing monitoring and may impact the effectiveness of current vaccines and therapies.
  • Urgent, equitable, and widespread vaccination, coupled with strict hygiene, is essential to control the pandemic driven by new variants.